Centene Corporation reported $202.9B of revenue over the trailing twelve months, +14% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $202.9B (to Q2 2026). Net income: −$5.10B, trailing twelve months to Q2 2026. Free cash flow: $8.95B, trailing twelve months to Q2 2026. Operating margin: −2.9%, trailing twelve months to Q2 2026.

CNCCentene Corporation

Healthcare

$65.37+103% 1Y

$65.37

$31.7752 weeks$69.42

CNC as reported

Centene Corporation reported $202.9B of revenue over the trailing twelve months, +14% on the year before. 11 reported series are charted on this page, each one as filed.

$202.9B

Revenue, trailing twelve months · to Q2 2026 · +14% against the twelve months before

Net income: −$5.10B
Net income · −348% year on year · trailing twelve months to Q2 2026
Free cash flow: $8.95B
Free cash flow · +729% year on year · trailing twelve months to Q2 2026
Operating margin: −2.9%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CNC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$202.9B	+14%	Q2 2026
Net income	−$5.10B	−348%	Q2 2026
EPS	−$10.44	−355%	Q2 2026
Gross margin	8.0%	n/a	Q2 2026
Operating margin	−2.9%	n/a	Q2 2026
Net margin	−2.6%	n/a	Q2 2026
ROE	−28%	n/a	Q2 2026
ROA	−7.3%	n/a	Q2 2026
ROIC	−35%	n/a	Q2 2026
Free cash flow	$8.95B	+729%	Q2 2026
P/E	11.2	n/a	Q2 2025 · 4 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.